Public Profile

Morganceutical

Morganceutical, a leading name in the pharmaceutical and biotechnology industry, is headquartered in Italy and operates extensively across Europe and North America. Founded in 2010, the company has rapidly established itself as a pioneer in innovative drug development and advanced therapeutic solutions. Specialising in precision medicine, Morganceutical offers a unique portfolio of products that focus on personalised treatment options, setting them apart in a competitive market. Their commitment to research and development has led to significant breakthroughs, positioning them as a trusted partner in healthcare. With a strong emphasis on quality and efficacy, Morganceutical continues to achieve notable milestones, reinforcing its reputation as a key player in the global pharmaceutical landscape.

DitchCarbon Score

How does Morganceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

3

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

Morganceutical's score of 3 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.

1%

Morganceutical's reported carbon emissions

Morganceutical, headquartered in Italy, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of information suggests that Morganceutical may still be in the early stages of developing a comprehensive climate strategy. As the industry increasingly prioritises sustainability, it will be essential for Morganceutical to establish clear emissions reduction goals and commitments to align with global climate standards.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Morganceutical's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Morganceutical is headquartered in IT, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Morganceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

Dionex China Limited

HK
Health Services
Updated 4 days ago

Irecruiti Medical Ltd

GB
Health Services
Updated 10 days ago

Chularat Hospital Public

TH
Health Services
Updated 10 days ago

Forma Vitrum, Inc

US
Health Services
Updated 3 days ago

Janssen

US
Health Services
Updated 10 days ago

MANAGED OCCUPATIONAL HEALTH LTD

GB
Health Services
Updated 10 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers